{"cmr":"us-cm-kg/NYSE/GSK","since":null,"total":304,"cursor":0,"limit":50,"next_cursor":50,"events":[{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-11-06","event_type":"results","title":"6-K — GSK PUBLISHES PROVISIONAL DIVIDEND DATES","category":"6-K","reference":"0001654954-26-009585","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009585/a1986c.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-11-06","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DSSGyYvLVpadLzZhC6vReUy5kkhGGkqrm_XQeq0N0pDlFODEiQxK3ZlIPHB34Mw6bkrA8CLnp5CH7hjkA19jCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-11-05","event_type":"regulatory_filing","title":"13F-HR","category":"13F-HR","reference":"0001999371-26-024635","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000199937126024635/xslForm13F_X02/primary_doc.xml","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-30","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EF3LDedqcqia1usNtaxgo7n0qJ1Y0BYBZYHpbyiact5r8gCJam-4W0JnH11KkA3kzatwOqLEwuo7mGyN7CD2Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-11-02","event_type":"results","title":"6-K — TOTAL VOTING RIGHTS","category":"6-K","reference":"0001654954-26-009362","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009362/a4168b.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-11-02","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NYWV2XFQR7t91KuoEgsU2zNDMrTaz2rvn8Zl1MbK9PAuBJu-7xvDi522Oq-tGRky2INuhSwYOLJmGEQmzRu5Cg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-28","event_type":"results","title":"6-K — 3RD QUARTER RESULTS","category":"6-K","reference":"0001654954-26-009181","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009181/a6993a.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-28","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"VurF-vni2xk_zgWWeq_RTKYMg5JfHE5SOULdjGBbPi_wIRPncQCOGUkgwu0Pc2RFBZAYyuTP3dfVupd80DkcDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-26","event_type":"results","title":"6-K — RIS-REZ POSITIVE PH 3 OSTEOSARCOMA DATA IN CHINA","category":"6-K","reference":"0001654954-26-009141","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009141/a4463a.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-26","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"okhfqnmtl0Qz9akGBmAbp9VLp1mb1Q-jUwWxi7x3VyCElYNyKJoH8mT0SztWGZJ2ojL_5RalmiSnscWhV3ltDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-26","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-009139","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009139/a4458a.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-26","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RemMZIpnJre0KS0Q3oYRHA_JnpglG7StBI11uhI2FAEp00itr1S0CynkmePqbxgtLdmAPgZ2dI9VcyOfxnx9Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-26","event_type":"results","title":"6-K — JEMPERLI DATA SHOW 76% COMPLETE RESPONSE RATE","category":"6-K","reference":"0001654954-26-009130","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009130/a3301a.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-26","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RaMnvP3ucGPN95yBCcHVxVUhOBDRgeR7g5Kbq9YRElz1NEo9taUfSHdwiPpFmVzH39-DUgLIPlMgQkoDH9fqDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-26","event_type":"results","title":"6-K — POSITIVE MO-REZ PHASE IB DATA IN OVARIAN CANCER","category":"6-K","reference":"0001654954-26-009127","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009127/a3306a.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-26","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"JnuPTSOapPgC92mFP9uETDi4R85vXwvEYwQWLBqvy0hC206LIbK6w-hTnOUfQsjk_2kkaaLnjKeoXhc0oN3_Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-21","event_type":"results","title":"6-K — US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B","category":"6-K","reference":"0001654954-26-009062","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009062/a7767z.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-21","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZPm1H19W1CVhc8t5GP5BOSuNQVP8Ee5SevL-S4fk8j8HkmlkUWi3yqb3YsoyY5ecDu5C0pLS9TPR5ZuOu-uJDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-19","event_type":"results","title":"6-K — JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER","category":"6-K","reference":"0001654954-26-009036","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009036/a5712z.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-19","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AO1O3ASDm9NRv0TSGSyr135gtOjGc3Lu0FCojjljQT6GhiyAiKkUomzzDcNgKIcW_J0LrxbxZxpDEB7KSQx1Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-19","event_type":"results","title":"6-K — RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER","category":"6-K","reference":"0001654954-26-009023","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426009023/a4743z.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-19","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hD5cnJf2S3OGc2OqQnZ2LJwIwTAkGicoSA6UqRfxyOWqLp0zuGxirjIqqQLROJ-LHfR9sgrHIgUu0O8gNyD5Aw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-15","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008959","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008959/a1338z.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-15","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uKiiDxWrNoA07OrtXcadRtB-ohEtT57Ftm2mHYHOGiAvBdvMm2ZWPSvLbUcxA7o31CjONlPGNNYU4An6YTNbCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-14","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008950","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008950/a0034z.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-14","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"M4hc5ZoNxoQZv4U17ncLzSL7xkGDB7s-VUIGkdwaWCizMMr5JQ5SQMaYofZUPAF2v5eEhFQ5OtHFhIS-m4afBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-13","event_type":"regulatory_filing","title":"S-8 — S-8","category":"S-8","reference":"0001193125-26-420025","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526420025/d28698ds8.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UH6WBWnrDgSxQgL_9Qoj9FvszfGEqYVF8BsQLjy9bm79kPAjEVNx_5y8ddvBY9w_r7RuyOOf9b-tgZvr6qofDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-13","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008921","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008921/a7978y.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-13","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XOVMdii15HhqjxFjSvU3DS0Ozc1h-DSZaBKiYP76PCu7vCZf0ZPJzO9sE4qlxBui9HdPAbjqZKsHhCfDaBxjDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-13","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008889","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008889/a6194y.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-13","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"r5xF4MMI9ITkmghBadsCmXJ8UZuSb-LBZWBT8scW6qoBTGprJKUf7sbdYrHf_fGlQRnU3Lunl9OV0Q8TFEoXDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-08","event_type":"results","title":"6-K — WENDY BECKER CBE - NEW DIRECTORSHIP","category":"6-K","reference":"0001654954-26-008854","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008854/a2299y.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-08","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TofoQN_erSokO3xQrVfJEqLRmKX2b5DAQPXEM04rAeyu6MJwVkqZYhcgt0_Wt7WvpRMBLbbmzBrnpEaSzHa9CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-06","event_type":"results","title":"6-K — ADMISSION TO TRADING","category":"6-K","reference":"0001654954-26-008813","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008813/a6826x.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-06","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lDHFVEh4PQKgIDnGOfne_jJntK7R-rm3oNeDkp5Ynz-Gfr6ovGr9FD3s0maK4NYFp_LAgsD_L7lrCg3wtktqAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-10-01","event_type":"results","title":"6-K — TOTAL VOTING RIGHTS","category":"6-K","reference":"0001654954-26-008733","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008733/a2043x.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-10-01","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9MbCM9sRpUALYlQOlMo7wrExy1pGAZtd1zE1lD36kwHqKCon4mbYWvT04FOA4-tjREmin1LLp6WUYTFCOcLNCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-24","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008553","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008553/a2127w.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-24","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NgCeQHzpxMBUtbvKNOiXmtgtaas2hvMbrTcJuucpFnMU9muLhmPSvFVIJcCV8zhjJF769RizHRfIxMERk2kVAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-22","event_type":"regulatory_filing","title":"CERT — NYSE CERTIFICATION","category":"CERT","reference":"0000876661-26-000783","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000087666126000783/GSK092226.pdf","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0H1htqJ3ba7Qp54CNPlZcAtWl5Vc_H_4d7cFFNeFeZJOMd6W9F-R7ugDNDIetqduUcoGXpXnAvy3yvNVyzLIAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-22","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008503","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008503/a8165v.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-22","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NY9M9HCTqrHBSqGBhDNiFhZPZD7ShOV4FdF8rL-SKFMq8Isq0XOpVQo4vdttPxBsb5PGcB4SNMoZHsos3cdvBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-15","event_type":"regulatory_filing","title":"8-A12B — 8-A12B","category":"8-A12B","reference":"0001193125-26-391619","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526391619/d339440d8a12b.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"YsFq2TOVTpYqf-gNq7-Zw-2H7RLaZfuvKAeTprZfG-oxWb7Elt1NGuk5HjXQMtJ5ZMx9X9lqO4GU-dOT4k00Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-15","event_type":"results","title":"6-K — 6-K","category":"6-K","reference":"0001193125-26-391597","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526391597/d180440d6k.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-15","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nuVhfZtFr5W2Gn_aVJ4Vmt8gBk94Wm07eTdlbiK3k3oIJrL8xOQ9Otta1e1QJVKbBX1lj_VzaujyZbmZ5-ZQAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-15","event_type":"results","title":"6-K — GSK TO ACQUIRE T CELL-ENGAGER FOR MULTIPLE MYELOMA","category":"6-K","reference":"0001654954-26-008359","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008359/a6888u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-15","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RVoSTfpJR-c5OraPDta6JjLOLYPFNXOPrbH9ILsMvX9AqP0JfeJSS6h3yvvboS9S7v8L6o5aRGFz4VpRdGdYAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-14","event_type":"results","title":"6-K — RIS-REZ POSITIVE PH 3 OS LUNG CANCER DATA IN CHINA","category":"6-K","reference":"0001654954-26-008321","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008321/a5437u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-14","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"znkd9cSe63pVsMNYw7zdzsxaEVsKpKLxRdm9kqjonGSTwVJWrrRXYyWzORsTnQhDwGAbGXT0UEY5Yo1PfFk0Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-14","event_type":"results","title":"6-K — JIDEYTRO POSITIVE DATA FOR ROS1-POSITIVE NSCLC","category":"6-K","reference":"0001654954-26-008318","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008318/a5235u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-14","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"IuK1VYP7G-3CHwLUZl3utpbF4ep80hkIwX8WPHm39FmI75IHm9zC-E007VfcZFIecVKdI-gVZ82GvfgilnskDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-11","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008280","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008280/a4618u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-11","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sZUEqN9zF251TBl0iczHUacBsJXYFvuQi6RDev9TtmjcECEjBJHlq8PVVtVGgEjY4l3TM-Jzzz5QzdIyzl8dAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-10","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008255","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008255/a2959u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-10","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_Ic2V966_ppgKdW-UYx-tTpMK7u93UY2FQZ3PDMMZHYInWdAN5-_qJUD1LPzGpCajlT_S99rd897wkjp6rtjDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-10","event_type":"prospectus","title":"424B2 — 424B2","category":"424B2","reference":"0001193125-26-387354","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526387354/d153434d424b2.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aT9ddcDekL6Ym0h9Ko4fA1A6hLuSkp12i6oVyHPReOa0YM2lreVhtL6OcMnv7JYXVpgCEza1r6FBp8jgLWLiCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-10","event_type":"results","title":"6-K — JAPAN APPROVAL OF SHINGRIX IN A PREFILLED SYRINGE","category":"6-K","reference":"0001654954-26-008234","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008234/a1355u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-10","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Yo5WTiMWUpogcdC1AzRdxbwLUxEHAGzodslY6NW2lHsblhihN1PHLB-8Qt-04Gzd0uNrSn99RB4ys-Eq86TpBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-09","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008205","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008205/a0968u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-09","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PyUHLR9RrdBCCajvvIqH8hXb-CAVqmkM9rMCu5o31QZfLRoa-lhoe5TNkb2mbSopJPso62oUaBRHR-piLTHUDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-09","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-008202","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008202/a0960u.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-09","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"tr7RN6jpvEVS2bewM9wrVDmIJeWAvxDwajJBuustGmm_bNkNvj401Z1VZkTxCt4QpYWTTFu2KleqUdHONLDIBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-09","event_type":"regulatory_filing","title":"FWP — FWP","category":"FWP","reference":"0001193125-26-385857","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526385857/d36790dfwp.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-Ugwt5cnHwi-ien7KmrzzFtT1wtRDVTU92gARc-uhcVaPotB_zeiGg27rrON0wogA2Pj9wdWAX5uSLa8PEepAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-08","event_type":"prospectus","title":"424B2 — 424B2","category":"424B2","reference":"0001193125-26-384490","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526384490/d300978d424b2.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EsFS89-sjLLNndGp2zpQwGUqc8g33aB9c0Xqm-fWHRswWSrReb2JkBg0GjIC20ra8ExVECTIP1FwTn0AF6-DAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-08","event_type":"results","title":"6-K — 6-K","category":"6-K","reference":"0001193125-26-384439","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526384439/d331501d6k.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-08","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"cyhxMP6xgzxN9P6u8N7ZG8ucpChdOpStl-fA5n8U7tZOOQAJXrLeUFTfI3ox0BTZsmV09y6FZBk8uF9E7WXyDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-01","event_type":"results","title":"6-K — TOTAL VOTING RIGHTS","category":"6-K","reference":"0001654954-26-008044","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426008044/a9126s.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-01","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9wobMjxDFMZYEOfl-hoqR0_8IXTLDGJjZ3w_ixRHLEDv80TJcd2tC0zVuSBNtA9DrFJ6q0KoKnrFamJhaLI9Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-09-01","event_type":"results","title":"6-K — MRNA FLU VACCINE CANDIDATE TO ADVANCE TO PHASE III","category":"6-K","reference":"0001654954-26-007998","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007998/a7703s.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-09-01","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"O_Mhb0hRLjn4Jyk748AlCCe5RqCQp_SMORIS5QkgAgOsTvxa8rJppg6pTHZz0bM1r9zOb5LyPXApSZcrXosACg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-26","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-007877","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007877/a2573s.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-26","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6PbSfxSpgl8_McUfevEEWqMu5A3J0VhWjTF-6RmP3vMCqEPWoBlqKexAR0LBjJf__N5lSC4w1E29DlOc_f71DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-24","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-007810","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007810/a9312r.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-24","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"raSB93BeEkeCYvSSUKwb5ajc_606QvRVWOVGM7s32PUwYPwZwpBDPKrnR41tft1e-6EgI0l7cXO4RNIX92VhBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-24","event_type":"results","title":"6-K — FIRST GLOBAL APPROVAL FOR HIBSAGO IN JAPAN","category":"6-K","reference":"0001654954-26-007800","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007800/a8443r.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-24","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NuJ__AOH5eNEKKyE76QzSp-7K5cdDfA6thW_G3ddY3nXFpPXAFny2tTZWWYUlzZWmM_celI4rEcss57HxPQlAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-24","event_type":"results","title":"6-K — US FDA TO REVIEW JEMPERLI FOR RECTAL CANCER","category":"6-K","reference":"0001654954-26-007798","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007798/a7607r.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-24","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5d93-hi28ou3d8EJnQCfsD1MdckSWPtnaRZSy4BkVObjZHxneBurMxyvn0VMBgBtk7KS0SgUKW0SEX2LpVEcAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-20","event_type":"regulatory_filing","title":"144","category":"144","reference":"0001949846-26-000534","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000194984626000534/xsl144X01/primary_doc.xml","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"l8-yrG6u7Va1gRFY_xdcIx2mOROD_S4SI7xI0cnZe5AbsjVfXPhcmhOwS22_Au9d5urn82TAid95R_YMm_TKBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-18","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-007718","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007718/a1253r.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-18","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"VUBpt4JQGJ_hQJfhvZgwqBWSjJgNdNelw0QfiHX20qx50345EuAne-8Qm01zkLbP17DN2Ec3S7t_wNql4lrHBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-13","event_type":"regulatory_filing","title":"SCHEDULE 13G/A","category":"SCHEDULE 13G/A","reference":"0001193125-26-349401","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000119312526349401/xslSCHEDULE_13G_X02/primary_doc.xml","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date ","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Hu9tfnxLWHRLAJvoerk4xbjLnLCPMd77yZlmwn5nwtZtu17ab3w7bQV3rXKCcrKl40x0r025aNTR1IRAXUyCBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-13","event_type":"regulatory_filing","title":"13F-HR","category":"13F-HR","reference":"0001999371-26-017873","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000199937126017873/xslForm13F_X02/primary_doc.xml","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-06-30","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BAviMlEx25gYQI9rKdcXl8QdQUI_cDzGbVQKPL5WEAFVp8hsRIdBPAXSGrKTIEc5k_LgoTs3Gyab8xFrVXcHBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-13","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-007560","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007560/a6279q.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-13","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"U3VQL65NI2EddoZf7dUCFeVVeD0Xiv1K77UurvPipexJPKG-bD6_G3m7-uyld7C1sDCqeBCCrg4QnO7EyfPYDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-11","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-007453","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007453/a2463q.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-11","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zDu4o1TKGYgm9ctmbJIGrs579_-Vzs7tMunOBIhzWSw8fVReRx2YTGtGzBY7mXLdTpGGQvZZ-_lfydQkM56VAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-08-03","event_type":"results","title":"6-K — TOTAL VOTING RIGHTS","category":"6-K","reference":"0001654954-26-007176","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007176/a9931o.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-08-03","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4Wh8NdQkbWstWZ9dlLi90LeRXS1cGBvki1h8H-8rOvJtr7RxxQCLdPkkIrNwzt79zj79kd02FoxZEvFWxrbZBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"us-cm-kg/NYSE/GSK","date":"2026-07-30","event_type":"results","title":"6-K — DIRECTOR/PDMR SHAREHOLDING","category":"6-K","reference":"0001654954-26-007005","language":"en","wire":"EDGAR","source":"SEC EDGAR filing index","url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426007005/a5890o.htm","read_by":"EDGAR submissions API (filings list per CIK)","detail":"report date 2026-07-30","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UXZihMouVKsGnVDXgofHpT_WmeqIiaxLtA7KcGrO6KQu8Je1jICN7fZirSSOBDzdLCD1owu-bJYf9_d8xub3DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}